Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHRONOS panitumumab rechallenge trial in metastatic colorectal cancer
2016-002597-12Phase 2Completed
- Sponsor
- Fondazione del Piemonte per l'Oncologia
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of panitumumab in metastatic colorectal adenocarcinoma (mCRC) and colon adenocarcinoma, sponsored by Fondazione del Piemonte per l'Oncologia. Primary endpoint: Overall response rate. Started Dec 2020; status: completed.
02
Drugs
panitumumab
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)colon adenocarcinoma
Beyond the preview
Go deeper on 2016-002597-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002597-12.